Clinical trial · Observational
Scandinavian Cohort Study for Optimal Use of Portal Vein Embolization
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Several aspects on the use of portal vein embolization (PVE) are poorly studied and todays recommendations are based on low-grade evidence. In this Scandinavian multicenter cohort study we will study some of the controversial aspects on the use of PVE to try to provide clearer answers on its optimal use. Six tertiary university hospital hepatobiliary units in Sweden, Norway and Denmark participate and contribute with all PVE procedures performed at their units during the study period. We will then study several aspects PVE technique in relation to induced hypertrophy and surgical outcome.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hepatic Neoplasm | Liver Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Portal vein embolization | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- rPVE
- description
- Right portal vein embolization. All patients subjected to selective right portal vein embolization prior to planned hepatobiliary surgery.
- interventionNames
- Procedure: Portal vein embolization
- label
- rPVE+S4
- description
- Right portal vein embolization including segment 4 portal vein branches. All patients subjected to selective right portal vein embolization including segment 4 portal vein branches prior to planned hepatobiliary surgery.
- interventionNames
- Procedure: Portal vein embolization
Primary outcomes (1)
- measure
- Future liver remnant hypertrophy
- timeFrame
- Based on radiology around 4 weeks before and after intervention
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Right-sided PVE Exclusion Criteria: * Left-sided PVE
References
Publications (0)
Data not yet available